Rama Lifescience Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 1.80 M
- Company Age 10 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.20 Cr
About Rama Lifescience
Rama Lifescience Private Limited (RLPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 September 2014 and has a history of Ten years and five months. Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Construction Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.80 M.
The company has closed loans amounting to ₹1.20 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Vaidehi Pendse and Anushri Anil serve as directors at the Company.
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74900PN2014PTC152429
- Company No.
152429
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Sep 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
What products or services does Rama Lifescience Private Limited offer?
Rama Lifescience Private Limited offers a wide range of products and services, including Elderly Care, Adult Diapers.
Who are the key members and board of directors at Rama Lifescience?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vaidehi Pendse  | Director | 04-Sep-2014 | Current |
| Anushri Anil | Director | 04-Sep-2014 | Current |
Financial Performance of Rama Lifescience.
Rama Lifescience Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Rama Lifescience?
In 2017, Rama Lifescience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Anushree Industries India Private LimitedAnushri Anil is a mutual person
Charges (Loans)
₹0
₹12.00 M
Charges Breakdown by Lending Institutions
- Others : 1.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Jun 2016 | Others | ₹1.20 Cr | Satisfied |
How Many Employees Work at Rama Lifescience?
Unlock and access historical data on people associated with Rama Lifescience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rama Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rama Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.